Related Experiment Videos
Early detection of leprosy in children
1SN Medical College, Agra, India.
Insights
Cell-mediated immunity protects children from leprosy infection. Monitoring immune status in contacts can identify those at risk for developing leprosy.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- Leprosy remains a significant public health concern, particularly in endemic regions.
- Understanding immune responses in contacts of leprosy patients is crucial for disease prevention strategies.
Purpose of the Study:
- To assess the immunological status of healthy children in contact with leprosy patients.
- To determine the correlation between immune markers and the development of overt leprosy disease in these children.
- To highlight the role of cell-mediated immunity in protection against leprosy.
Main Methods:
- Assessed humoral immunity using the Fluorescent Leprosy Antibody Absorption Technique (FLA-ABS).
- Assessed cell-mediated immunity using the Lepromin test.
- Followed 200 healthy child contacts for 2.5 years to monitor disease development.
- Classified children into four groups based on FLA-ABS and Lepromin test results.
Main Results:
- Children with strong cell-mediated immunity (Group I) did not develop leprosy despite infection.
- Children with positive humoral immunity but negative cell-mediated immunity (Group II) had a higher incidence of disease (15/37).
- No children with negative humoral and positive cell-mediated immunity (Group III) or negative for both (Group IV) developed overt disease.
- Findings were statistically significant (P < 0.01).
Conclusions:
- Cell-mediated immunity plays a critical protective role against the development of leprosy.
- Immune surveillance in endemic populations can identify at-risk individuals for targeted follow-up.
- Further research into immune-based interventions for leprosy prevention is warranted.
Abstract:
Healthy children contacts of leprosy patients had their humoral and cell-mediated immunological status assessed using the Fluorescent Leprosy Antibody Absorption Technique (FLA-ABS) and the Lepromin test, respectively. Subsequently, they were followed up for 2 1/2 years to study the development of overt disease. Two-hundred children were studied and classified into four groups, viz. Group I comprised of children who were FLA-ABS positive and Lepromin positive; Group II = FLA-ABS positive and Lepromin negative; Group III = FLA-ABS negative and Lepromin positive; Group IV = FLA-ABS negative and Lepromin negative. The good cell-mediated immune (CMI) response in the 107 children in Group I prevented them from developing the disease though they had been infected. Out of the 37 children in Group II, 15 developed the disease. There were no children in Group III. None of the 56 children in Group IV developed the disease, possibly because they had not been significantly infected. All these findings were statistically significant (P less than 0.01). This study highlights the protective role of cell-mediated immunity in leprosy. It also suggests the need to carry out surveillance surveys in the endemic population to identify and follow up those at risk.